Melanoma is a serious, potentially lethal disease. It is one of very few common cancers whose incidence is rising in North America. The objective of this study was to examine trends in melanoma incidence in Ontario, Canada’s most populous province, over the past 20 years. Using data from the Ontario Cancer Registry (OCR), this retrospective cohort examined all incident cases of melanoma in Ontario from 1990 to 2012. Generalized linear modeling was used to evaluate changes in melanoma incidence over time, adjusting for age and sex using direct standardization with the 1991 Canadian census population. Tests for trend for changes in the distribution of cases by age, sex, socioeconomic status, and rurality status were also calculated. Our results show a statistically significant increasing incidence of melanoma in Ontario from 9.3 cases per 100 000 in 1990 to 18.0 cases per 100 000 in 2012 (P for trend <.001, adjusted for age and sex). Incidence rates show stabilization from 2010 to 2012. Our study reveals a marked increase in melanoma incidence in Ontario, more than doubling over the past 20 years but with a stabilization more recently. Adequate availability of dermatology services may be important to ensure satisfactory care for the increased caseload and to ensure that cases may detected at an early stage with a good prognosis.
20 September 2018 in Cochrane Database of Systematic Reviews
Hypopigmented mycosis fungoides (MF) is a rare variant of mycosis fungoides that creates diagnostic challenges as it can mimic other more common hypopigmented skin conditions clinically. Herein we present a case of a 31-year-old female with hypopigmented MF with typical histopathological features and excellent response to narrow-band ultraviolet B phototherapy combined with mid-potency topical corticosteroids.
The 33rd congress of the European Academy of Dermatology and Venereology (EADV) was held in Amsterdam, the Netherlands from Sept 24–28, 2024. With over 17,000 participants, this meeting had the highest attendance of any EADV congress to date. The meeting featured over 160 symposia and 20 subspecialty sessions and provided updates and data on new and emerging therapies for a number of skin conditions. This article will highlight interesting findings in atopic dermatitis, psoriasis, and hidradenitis suppurativa (HS).